Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Background: Hepatocellular carcinoma (HCC) is the most invasive form of liver cancer. Despite major improvements in diagnosis and treatment of early HCC, the prognosis is still very poor. The current targeted therapy generally has low tumor response rates and substantial side effects, so it is necessary to explore other types of targeted therapy against HCC